Depression News and Research

Latest Depression News and Research

Youth suicide on steady decline in Washington

The rate of youth suicide in our state has significantly declined. The Washington State Department of Health’s Youth Suicide Prevention Program (YSPP) reported a 16 percent decline in suicide among the 15-24 age group over a 10-year period (1993-2002).

8 Sep 2004

Gene linked to both alcoholism and depression

A national team of investigators led by psychiatric geneticists at Washington University School of Medicine in St. Louis has identified a gene that appears to be linked to both alcoholism and depression.

8 Sep 2004

Depressed patients may need treatment for both physical and emotional symptoms

Physical symptoms (such as headache, back pain, stomach problems, joint or muscle pains, and dizziness) are nearly as common in depression as emotional symptoms and are the predominant complaint depressed patients present with in the primary care setting.

8 Sep 2004

Study shows that naturopathic medicine helps women experiencing jaw pains

A study involving a painful jaw disorder and the role of naturopathic medicine demonstrates how this holistic approach to care can empower patients to improve their own health.

8 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

ADHD children four times more likely to have mental health problems when they grow up

Many normal children display low levels of the traits associated with ADHD – behaving in an impulsive, inattentive, and restless fashion – which will not cause problems.

8 Sep 2004

Australian research studies health impacts of living in a high-rise apartment

More Australians are choosing to live in inner city high-rise apartments with estimates for Melbourne and Sydney pointing to a three-fold increase in this style of living. But are those living high living healthy?

7 Sep 2004

Pediatricians do not always feel comfortable or sufficiently trained to tackle the increasing growth in ADHD patient numbers

Attention Deficit Hyperactivity Disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. Today pediatricians appear to be treating more children with these behavioral health problems.

7 Sep 2004

People should be aware of the risks of herbal remedies interacting with conventional medicines

A high percentage of the population could be endangering their health by taking herbal medicines without checking with a health professional first according to Peter Houghton, Professor in Pharmacognosy, King’s College London.

7 Sep 2004

Research suggests that victimisation in childhood increases risk of psychotic disorders, such as schizophrenia or manic depression

People with psychosis report a marked excess of victimising experiences, many of which occurred during childhood, according to a new study.

2 Sep 2004

Rural doctors less likely to diagnose depression in men than in women

It is known that doctors are generally less likely to diagnose depression in men than in women. Little research has been undertaken to explore the reasons for this in rural settings, or to compare GPs' and male patients' assessments of perceived depression.

2 Sep 2004

Researchers work to defeat acne by understanding it better on a molecular level

To defeat an enemy, you must first understand it, or so the saying goes. And for nearly every teenager and young adult, acne is a formidable foe, causing damage to their skin and their self-image that can leave long-lasting physical and emotional scars.

2 Sep 2004

Mental distress increases risk of heart disease in diabetics

“Mental health professionals need to be involved in the care of diabetic persons,” says study author Tara W. Strine, M.P.H., an epidemiologist in the Division of Adult and Community Health at the Centers for Disease Control and Prevention. The findings appear in the American Journal of Health Behavior.

30 Aug 2004

New study confirms benefits of rimonabant in weight loss

Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight

29 Aug 2004

U.S. FDA study shows Canadian drugs to be more expensive

If you think all drugs from Canada are cheaper than U.S. drugs, think again. In the United States, generic drugs - roughly half of all prescriptions - are often cheaper than both Canadian brand-name drugs and Canadian generic drugs, according to a study by the Food and Drug Administration.

29 Aug 2004

First study of the emotional turmoil caregivers experience during the transition of their loved one from home to care facilities

A new study shows that caregivers of dementia patients who must make the difficult decision to place their relatives into institutionalized care get no relief from depression and anxiety, and in fact suffer additional emotional trauma following their decision.

26 Aug 2004

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company has announced.

26 Aug 2004

FDA reinforces use of Sustiva in first-line HIV combination therapy

Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.

26 Aug 2004

Prozac helps treat adolescents with depression

The TADS researchers said that major depressive disorder is common, with one in 20 teens affected at varying levels of severity. Like other forms of depression, major depressive disorder has been associated with increased risk of suicidal behavior and with completed suicide.

26 Aug 2004

Cymbalta, a new treatment for major depression

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.

25 Aug 2004